GENERAL CABLE: CONGRATULATIONS YOU TRIPLED YOUR MONEY IN A CASH BUYOUT OFFER, 131ST BUYOUT OF OUR PORTFOLIO COMPANIES $BGC $NVS $AAAP

GENERAL CABLE: CONGRATULATIONS YOU TRIPLED YOUR MONEY IN A CASH BUYOUT OFFER, 131ST BUYOUT OF OUR PORTFOLIO COMPANIES $BGC $NVS $AAAP

This post was just published on ZYX Buy Change Alert.

A large number of subscribers are holding General Cable (BGC) stock from $10.  Newer subscribers are holding BGC from as high as $21.  BGC has received a $30 cash buyout offer from Prysmian Group.  The Arora Report had previously identified BGC as a takeover target.

A large number of subscribers have almost tripled their money.

The Arora Report subscribers have benefited tremendously from our propensity to find buyout targets in advance.  This is the 131st buyout of an Arora Report portfolio company.  The 130th buyout was of Advanced Accelerator Applications (AAAP) which has been  bought out by  Novartis (NVS).  The Arora Report subscribers doubled their money in that buyout.

What To Do Now

The transaction is likely to close in the second half of 2018.  We do not expect a higher offer but that is always a possibility.  What to do now depends on your personal preference.  The stock is trading at $29.30 as of this writing.  There will be over 3% additional return  if the stock is held and ultimately tendered at $30.  However for some subscribers there may be better uses of cash.

Trades posted on The Arora Report Market Blog have produced unrivalled performance since 2007.  Please click here and scroll down to see the table of all trades.  These trades have been scrutinized in real-time by thousands of investors across the globe.  This provides easy verification of performance for newcomers to this site.  Only those trades are included in the performance where the entry post was made available to subscribers to The Arora Report Market Blog.  When the entry post is made available only to the paying subscribers and not posted in real-time on The Arora Report Market Blog, the resulting performance of the trade is not credited in the performance table.  There are very nice gains on this trade but since the entry trade was not posted here for the free subscribers in real-time but only made available to the paying subscribers, handsome profits on this trade will not be added to the performance of The Arora Report Market Blog shown on the table. 

You are receiving less than 2% of the content from our paid services …TO RECEIVE REMAINING 98%, TAKE A FREE TRIAL TO PAID SERVICES.

Please click here to take advantage of a FREE  30 day trial.

Check out our enviable performance in both bull and bear markets.

FREE: SUBSCRIBE TO ‘GENERATE WEALTH’ NEWSLETTER

Related Posts

AFTER DOUBLING MONEY IN THIS FAMOUS BIOTECH RELATED TO APPLE, WHAT IS NEXT? $AAAP $AAPL $NEOS $NVS $PDLI $GILD $JUNO $ZIOP $BLCM $BLUE

Not long ago, French pharmaceutical company Advanced Accelerator Applications got a lot of publicity. Now it’s getting bought out. The late ...

CONGRATULATIONS IF YOU FOLLOWED US IN ADVANCED ACCELERATOR APPLICATIONS, YOU DOUBLED YOUR MONEY IN THE BUYOUT, 130TH BUYOUT $AAAP $NVS

This post was just published on ZYX Buy Change Alert. Advanced Accelerator Applications (AAAP) stock is long from $40.50. AAAP has received an $82 ...

AAAP: GOOD NEWS FOR TREATMENT OF THE CANCER THAT KILLED STEVE JOBS OF APPLE $AAPL $AAAP $NVS

This post was just published on ZYX Buy Change Alert. Advanced Accelerator Applications (AAAP) stock is long from $40.50.  As of this writing it ...

OUR POSITION ADVANCED ACCELERATOR APPLICATION STOCK JUMPING ON BUYOUT RUMORS, STEVE JOBS’ CANCER $AAAP $AAPL $NVS

This post was published on ZYX Buy Change Alert. Advanced Accelerator Application (AAAP) stock  is long from $40.50.  It traded as high as $70 ...

ADVANCED ACCELERATOR APPLICATIONS, STEVE JOBS CANCER DRUG COMPANY, BREAKING OUT $AAAP $AAPL $XBI $IBB

This post was just published on ZYX Buy Change Alert.  AAAP, Steve Jobs cancer drug company, appears to be breaking out.  Please see ...

A NEW TRADE IDEA: BIOTECH COMPANY MAY HAVE A CURE FOR THE CANCER THAT KILLED APPLE’S STEVE JOBS $AAAP $AAPL $IBB $LABD $XBI $LABU

I’m constantly exposed to speculative biotechnology companies with promising treatments. But few pass our investing screens. Advanced Accelerator Applications SA AAAP,  ...

INDIA COURT RULING AGAINST NOVARTIS IS DARK OMEN FOR BIG PHARMA $NVS $LLY $BMY $MRK $JNJ $PFE

It is official: India is siding with poor cancer patients over profits for multinational drug giants. The Supreme Court of India has rejected ...

HOW TO PROFIT FROM THE GREEK ELECTION

As of this writing, the wire reports are that the New Democracy party may be able to form a governing ...

Follow

Get every new post delivered to your Inbox

Join other followers